Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
企業コードALUR
会社名Allurion Technologies Inc
上場日Mar 29, 2021
最高経営責任者「CEO」Dr. Shantanu Gaur, M.D.
従業員数134
証券種類Ordinary Share
決算期末Mar 29
本社所在地11 Huron Dr Ste 200
都市NATICK
証券取引所NYSE Consolidated
国United States of America
郵便番号01760
電話番号15086474000
ウェブサイトhttps://www.allurion.com/en
企業コードALUR
上場日Mar 29, 2021
最高経営責任者「CEO」Dr. Shantanu Gaur, M.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし